AstraZeneca, Merck report positive long-term data for Lynparza
AstraZeneca (AZN) and Merck (MRK) reported positive long-term survival data for their drug Lynparza in the treatment of ...
aha.org23h
Baxter restores additional IV solutions production lines
Baxter has resumed production on all of its 3-liter irrigation and peritoneal dialysis solutions manufacturing lines, the ...
Lisata completes subject enrolment in multi-cancer trial of certepetide
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js ...
Excellent Recovery of a 26-Week, 990g Miracle Baby at Jehangir Hospital, Pune
PNN Pune Maharashtra [India] 11 Caring for extremely preterm babies requires exceptional teamwork and expertise A 26-week ...
Former Tory party chairman Lord Saatchi ‘finds love again’ 13 years after being widowed
Advertising guru in relationship with philanthropist Lady de Rothschild, with whom he launched bid for The Telegraph ...
The Washington Informer31m
Chronic Kidney Disease is an Urgent Health Crisis in the Black Community
Explore the disproportionate burden of chronic kidney disease in the Black community and the need for empowerment and ...
Medscape7h
Eye Toxicities Are a Growing Concern With Certain ADCs
Some antibody-drug conjugates may cause such significant ocular toxicity that patients have vision damage or have to stop ...
Maurice Saatchi considered ‘ending it all’ after wife's death - then found love at 79
The former Saatchi & Saatchi powerhouse reveals he is in a new relationship with Lynn Forester de Rothschild, 12 years after ...
Le Lézard4h
LYNPARZA® (olaparib) Demonstrated Clinically Meaningful Prolonged Survival Benefit in Early Breast Cancer in OlympiA Phase 3 Trial
AstraZeneca and Merck , known as MSD outside of the United States and Canada, today announced long-term results from the OlympiA Phase 3 trial which showed LYNPARZA (olaparib) demonstrated sustained, ...
Le Lézard4h
LYNPARZA® (olaparib) demonstrated clinically meaningful prolonged survival benefit in early breast cancer in OlympiA Phase III trial
Updated results from the OlympiA Phase III trial showed AstraZeneca and Merck & Co., Inc's, known as MSD outside of the US and Canada, LYNPARZA® (olaparib) demonstrated sustained, clinically ...
Daily7h
Phase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival in Patients With Advanced Epithelial Ovarian Cancer: Merck
Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYLYNK-001 trial ...